0001562180-17-003867.txt : 20171213 0001562180-17-003867.hdr.sgml : 20171213 20171213195337 ACCESSION NUMBER: 0001562180-17-003867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171211 FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lehman David Aaron CENTRAL INDEX KEY: 0001354228 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 171254963 MAIL ADDRESS: STREET 1: 6035 STONERIDGE DRIVE CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-12-11 false 0001271214 Intersect ENT, Inc. XENT 0001354228 Lehman David Aaron C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 false true false false General Counsel Common Stock 2017-12-11 4 M false 36000.00 18.00 A 45000.00 D Common Stock 2017-12-11 4 S false 36000.00 32.75 D 9000.00 D Stock Option (right to buy) 18.00 2017-12-11 4 M false 36000.00 0.00 D 2026-02-21 Common Stock 36000.00 94000.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.00, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4. The vesting commencement date of the option is February 22, 2016. 25% of the shares subject to the option shall vest on February 22, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years. /s/ David A. Lehman 2017-12-13